Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Centauri Therapeutics logo

Centauri Therapeutics

Recent Finacing

Series A II

Recent Raise

$8.1M

Centauri Therapeutics is a UK immunotherapy company using its proprietary Alphamer® platform to create broad-spectrum antimicrobials for multidrug-resistant Gram-negative bacterial infections.

Founded 2015
Cheshire, United Kingdom
11-50
Private
centauritherapeutics.com
PitchBook

Highlights

Focus Areas

Biotechnology
Genetics
Health Care
Medical
Therapeutics

Recent Investors

A
CARB-X logo
Evotec logo
Boehringer Ingelheim logo
Wren Capital logo
Novo Holdings logo
K
AMR Action Fund logo
Pace Ventures logo

Financials

$54.2M

Total Raised

7

Funding rounds

8

Investors


Team

Upgrade to view the team

See the team members at Centauri Therapeutics.